Again as I previously stated I copied and pasted that link with the post #. And now I'm doing the same again, so everyone can see what I'm seeing, this post is from DCGod-
Post #17131-
It's pretty clear where Ken is getting funds now. First of all, Ken is a pharmacist at Aliton's Pharmacy, operates his own company called Manzo Pharmaceuticals and he invented the lactose product that is being talked about. It appears he licensed his patent to a company called MedGen which is also creating a lactose product. Ken LICENSED the patent to MedGen for a large amount of shares. IMO, FOGC is a serious GOLDMINE since Ken not only is making $ from the MedGen deal but he can also create a product himself using his exact same technology since the licensing deal apparently did not include a non compete disclosure. This is huge and should show others he is indeed is able to pay for bringing this product to market himself. I feel we are witnessing Ken's attempt to beat MedGens product to market and what better way to do this than to be the inventor yourself?
IMO, Ken sold the license to MedGen so he could fund his own startup to launch his own product with his own patent. Who would you rather buy the product from, the inventor or a person licensed to use the patent?!?!? $$$$$$$$$$$$$$$
This is a major WIN WIN for Ken since he can use the funds from MedGen (if they are successful bringing the product to market) to fund his own product coming to market. GENIUS. And we all know, every great inventor never licenses ALL of their great ideas. I feel Ken has something special or a major breakthrough that he can add to his own product and shoot right past any of MedGen's attempts when the time is right.
IMO, Ken bought this FOGC shell in order to raise and support brining the Lactose Freedom product to market quickly after a lackluster attempt at crowd funding on MedStartr. When investors spread the word about Manzo's product I feel this ticker will explode in market cap and give him a MUCH better chance at actually brining this product to market.
Here is a link to MDIN which purchased a license to use Ken's patent for, from what I gather, 500 million shares
Sorry I couldn't copy the link but it goes to MDIN post #87686
